Paul N. Durrington

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Paraoxonase and Atherosclerosis

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins

Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

ESC/EAS Guidelines for the management of dyslipidaemias

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins